The Northern New England Perinatal Quality Improvement Network is partnering with NH Department of Health & Human Services and two national initiatives, CDC’s ERASE Maternal Mortality and The Alliance for Innovation on Maternal Health (AIM), to provide a webinar discussion on the prevalence of Xylazine in regional drug supply, the pharmacology and toxicity of this drug in humans, and the impact Xylazine has on treatment engagement and possible harm reduction strategies.
Note: The events contained in this calendar are subject to change without notice by their respective organizers. Refer to each event's website for updates.